NBCC Q1 FY27 Results Analysis: PAT Jumps 32%, Real Estate Monetisation Accelerates
NBCC (India) Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 1,823.04 Cr (+10.04% YoY) and PAT growth of +32.06% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | August 11, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 1,823.04 Cr (+10.04% YoY) |
| PAT (Q1) | Rs. 150.65 Cr (+32.06% YoY) |
| EBITDA margin | 8.77% (+281 bps YoY) |
| EPS (Q1) | Rs. 0.56 (+33.33% YoY) |
| Market cap | Rs. 25,379.52 Cr |
| CMP | Rs. 93.80 |
Quarter Snapshot
NBCC delivered strong standalone performance with 10% revenue growth, 32% PAT growth, and EBITDA margin expanding to 8.77%, within the guided band. Real estate monetisation accelerated sharply, achieving over half the annual target in Q1. However, consolidated results were dragged by HSCC subsidiary issues and the EPC segment is winding down. Strong order inflow and improving margins support a positive outlook despite structural challenges in subsidiaries.
Key Investment Insights
Key Positives
- Standalone revenue grew 10.04% YoY to Rs.1,823.04 Cr, PAT grew 32.06% to Rs.150.65 Cr.
- Standalone EBITDA margin expanded 281 bps YoY to 8.77%, within the guided 8-9% band.
- Real Estate segment revenue surged 140.8% YoY to Rs.53.90 Cr, achieving 54% of FY target in Q1.
- PMC segment revenue grew 12.15% YoY and EBIT margin expanded 132 bps to 10.78%.
- Order inflow strong: Q1 works awarded Rs.955.13 Cr, post-Q1 orders ~Rs.2,847 Cr.
Risk Factors
- Consolidated revenue declined 5.56% YoY due to HSCC subsidiary revenue reversal from Test-to-Treat issue.
- Subsidiary PAT contribution fell from Rs.18.05 Cr to Rs.4.18 Cr, indicating thin margins at HSCC.
- EPC segment revenue collapsed 94.46% YoY to Rs.3.96 Cr and reported a loss of Rs.6.08 Cr.
- Auditor flagged board composition (only one woman director) and un-quantified managerial remuneration comments.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.